Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
12/2003
12/31/2003WO2004000367A1 Ace2 activation for treatment of heart, lung and kidney disease and hypertension
12/31/2003WO2004000349A1 Pharmaceutical preparation and method of treatment of human malignancies with arginine deprivation
12/31/2003WO2004000343A1 Recombinant polypeptide for immunocastration and vaccine comprising the same
12/31/2003WO2004000221A2 Compositions and methods for modulating lymphocyte activity
12/31/2003WO2004000207A2 Toxin-phage bacteriocide antibiotic and uses thereof
12/31/2003WO2004000164A2 Amniotic membrane mediated delivery of bioactive molecules
12/31/2003WO2004000102A2 Method for predicting response to epidermal growth factor receptor-directed therapy
12/31/2003WO2004000015A2 Compositions and methods for improving plant performance
12/31/2003WO2004000011A2 Methods for developing animal models
12/31/2003WO2004000010A2 Animal models of prostate cancer and methods for their use
12/31/2003WO2004000008A1 A method for increasing resistance of monocot plants against abiotic stresses
12/31/2003WO2004000007A2 Methods of modulating cytokinin related processes in a plant using b3 domain proteins
12/31/2003WO2004000006A2 Method of transforming soybean
12/31/2003WO2003087774A3 Ecist microarrays for dual screening of dna hypermethylation and gene silencing
12/31/2003WO2003087336A3 Estrogen receptor alpha regulated gene expression, related assays and therapeutics
12/31/2003WO2003087308A3 Use of interleukin-24 to treat ovarian cancer
12/31/2003WO2003081990A3 Improved method for generating genetically modified animals
12/31/2003WO2003080869A3 Storing and detecting nucleic acid administered to a solid carrier
12/31/2003WO2003080834A3 Purification methods for oligonucleotides and their analogs
12/31/2003WO2003078627A3 A building block capable of functional entity transfer to nucleophil
12/31/2003WO2003078446A3 A building block forming a c-c or a c-hetero atom bond upon reaction
12/31/2003WO2003076633A3 Inhibition of germination in plants
12/31/2003WO2003075129A3 Methods, systems, and software for identifying functional bio-molecules
12/31/2003WO2003073918A3 Prevention of recurrence and metastasis of cancer
12/31/2003WO2003072704A3 RNA INTERFERENCE MEDIATED INHIBITION OF PLATELET DERIVED GROWTH FACTOR (PDGF) AND PLATELET DERIVED GROWTH FACTOR RECEPTOR (PDGFR) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
12/31/2003WO2003072036A3 Treatment methods using anti-cd22 antibodies
12/31/2003WO2003070980A3 Nucleic acid quantification
12/31/2003WO2003070876A3 Method for attaching nucleic acid molecules to electrically conductive surfaces
12/31/2003WO2003068939A3 Cks1 INHIBITORS
12/31/2003WO2003068811A3 Cytotoxic t-cell epitopes from chlamydia
12/31/2003WO2003067965A3 Identification and characterization of an glutamine dumper 1 phenotype (gdui1) in arabidopsis
12/31/2003WO2003065795A3 An invertebrate animal model with neurodegenerative phenotype for screening and testing substances
12/31/2003WO2003064638A3 Elongase gene and method for producing polyunsaturated fatty acids
12/31/2003WO2003064607A3 Clinical grade vectors based on natural microflora for use in delivering therapeutic compositions
12/31/2003WO2003064471A3 Gene for peripheral arterial occlusive disease
12/31/2003WO2003064465A3 Prkag3 gene promoter and uses thereof
12/31/2003WO2003062376A3 Molecules for diagnostics and therapeutics
12/31/2003WO2003061573A3 Methods and compositions for treating urological disorders using 1435, 559, 34021, 44099, 25278, 641, 260, 55089, 21407, 42032, 46656, 62553, 302, 323, 12303, 985, 13237, 13601, 18926, 318, 2058 or 6351 mo
12/31/2003WO2003057834A3 Expression of protective antigens in transgenic chloroplasts and the production of improved vaccines
12/31/2003WO2003057708A3 Fusion proteins
12/31/2003WO2003056034A3 Method for the in vitro selection of binders
12/31/2003WO2003056022A3 Method for producing a transgenic organism using a lentiviral expression vector such as eiav
12/31/2003WO2003056021A3 Modified tetracycline repressor protein compositions and methods of use
12/31/2003WO2003055916A3 Adiponectin fragments and conjugates
12/31/2003WO2003055912A3 Secreted proteins
12/31/2003WO2003054151A3 Generation of transgenic mice by transgene-mediated rescue of spermatogenesis
12/31/2003WO2003052138A3 Methods of detecting modification of genetic material
12/31/2003WO2003048310A3 Thermus oshimai nucleic acid polymerases
12/31/2003WO2003048208A3 Expression control using variable intergenic sequences
12/31/2003WO2003046129A3 Compositions for the derivation of germ cells from stem cells and methods of use thereof
12/31/2003WO2003044166A3 METHODS AND COMPOSITIONS FOR REGULATION OF GENE EXPRESSION THROUGH MODULATION OF mRNA TURNOVER
12/31/2003WO2003040408A3 Detection of predisposition to osteoporosis
12/31/2003WO2003040335A3 Engineering of leader peptides for the secretion of recombinant proteins in bacteria
12/31/2003WO2003039344A3 Methods and compositions for correction of cardiac conduction disturbances
12/31/2003WO2003033734A3 Diagnostic tests for the diagnosis of copper storage disease
12/31/2003WO2003031965A3 Microfluidic extraction method
12/31/2003WO2003027122A3 Lanthanide binding tags
12/31/2003WO2003025174A3 Regulation of human mrp1-like protein
12/31/2003WO2003023035A3 Glucosyltransferases which glucosylate abscisic acid
12/31/2003WO2003022879B1 Peptides mimicking a cryptic epitope of gp41 hiv-1 and antibodies directed against them
12/31/2003WO2003020759A9 A caspase- 8 binding protein, its preparation and use
12/31/2003WO2003016527A3 Process for the detection of oxidative stress and kit for its implementation
12/31/2003WO2003010286A9 Nucleic acids, polypeptides, and methods for modulating apoptosis
12/31/2003WO2003010176A3 Protein-nucleic acid complexes
12/31/2003WO2003006492A3 Biologically active peptides
12/31/2003WO2002101232A3 Bace interacting proteins
12/31/2003WO2002101010A3 Methods and compositions for modulating telomerase reverse transcriptase (tert) expression
12/31/2003WO2002101006A3 Production of proteins in plants
12/31/2003WO2002097059B1 Chromosome-based platforms
12/31/2003WO2002094986A3 Next-nearest-neighbor sequence determinants of antisense dna
12/31/2003WO2002077648A3 Pathogenic and commensal vaccine antigens
12/31/2003WO2002077220A3 Nucleic acids encoding human est1 proteins
12/31/2003WO2002070740A3 Test system for determining gene toxicities
12/31/2003WO2002070562A3 Nuclear hormone receptor ligand binding domain
12/31/2003WO2002067971A3 Use of endostatin in the treatment of ocular neovascularization
12/31/2003WO2002064796A3 Butyrylcholinesterase polypeptide variants with increased catalytic efficiency and methods of use
12/31/2003WO2002064764A3 Terpene synthase/cyclase and olefin synthase and uses thereof
12/31/2003WO2002059136A8 Immunoglobulin class switch recombination
12/31/2003WO2002057469A3 Modulating developmental transitions in plants
12/31/2003WO2002055668A3 Nucleotide sequences encoding variable regions of heavy and light chains of monoclonal antibody 1f7
12/31/2003WO2002053701A9 Epididymal lipocalin gene and uses thereof
12/31/2003WO2002042444A3 Fungal gene cluster associated with pathogenesis
12/31/2003WO2002042325A3 Cyp1b1 nucleic acids and methods of use
12/31/2003WO2002040718A3 Method to identify genes associated with chronic myelogenous leukemia
12/31/2003WO2002040671A3 Immunoglobulin superfamily proteins
12/31/2003WO2002040650A3 Methods for large scale production of recombinant dna-derived tpa or k2s molecules
12/31/2003WO2002038766A3 Human tumor necrosis factor receptor
12/31/2003WO2002036820A8 Methods for assessing the risk of non-insulin-dependent diabetes mellitus based on allelic variations in the 5'-flanking region of the insulin gene and body fat
12/31/2003WO2002036789A3 Methods of modifying eukaryotic cells
12/31/2003WO2002031198A3 Cancer-linked genes as targets for chemotherapy
12/31/2003WO2002018635A8 Use of nonviable particles comprising an internal control (ic) nucleic acid
12/31/2003WO2001088197A3 Methods and compositions for interaction trap assays
12/31/2003WO2000043409A3 Alpha-conotoxin peptides
12/31/2003CN1464908A Multivalent antibodies and uses therefor
12/31/2003CN1464907A Novel rice gene regulating salt stress tolerance
12/31/2003CN1464790A T cell receptor fusions and conjugates and methods of use thereof
12/31/2003CN1464068A Human brain tissue specificity molecular marker LRRC4
12/31/2003CN1464062A Expression vector pBVTB, its construction method and use in HCV vaccin research
12/31/2003CN1464061A Bean culture pattern schema regulating gene and use thereof
12/31/2003CN1464060A Bridsfoot trefoil pattern schema and anthotaxis structure regulating gene encoding protein and use thereof
1 ... 2342 2343 2344 2345 2346 2347 2348 2349 2350 2351 2352 2353 2354 2355 2356 2357 2358 2359 2360 2361 2362 ... 4023